Volume 14 Supplement 1
Publication charges for this supplement were funded by 3P Solution, Milan, Italy. PAA has acted in a consultant/advisory role for BMS, Roche-Genentech, MSD, Ventana, Novartis and Amgen and has received research funding from BMS, Roche-Genentech and Ventana. The other Supplement Editors declare that they have no competing interests.
Naples, Italy1-5 December 2015
Edited by Paolo A Ascierto, Francesco M Marincola and Nicolar Mozzillo.
MELANOMA BRIDGE 2015
Citation Impact 2023
Journal Impact Factor: 6.1
5-year Journal Impact Factor: 6.2
Source Normalized Impact per Paper (SNIP): 1.234
SCImago Journal Rank (SJR): 1.611
Speed 2023
Submission to first editorial decision (median days): 9
Submission to acceptance (median days): 86
Usage 2023
Downloads: 4,999,990
Altmetric mentions: 8,678